ematologically, myelosuppressives such as cyclophosphamide (Cy) and 5-fluorouracil (5FU) transiently suppress bone marrow (BM), but then enhance its activity and mobilize stem/progenitor cells including BM-CD34 + cells into circulation. 1 BM cell transplantation and G-CSF improve left ventricular (LV) remodeling and function after myocardial infarction (MI) via mobilization of the cells and/or repair-related cytokines. 2-5 Therefore, we investigated the therapeutic potency of Cy and 5FU for MI.
XL, Beckman Coulter). The LV end-diastolic dimension (EDD/body weight (BW), mm/kg) and LV ejection fraction (EF, %) were echocardiographically measured before MI and on Day 28. After death, the LV was weighed, and stained immunohistochemically with -sarcomeric actin to measure the LV wall area, infarcted and surviving areas, or with CD31 for counting the vessel density in the infarcted area. 5 Six rabbits from each group were killed on Day 7 for Western analysis of matrix metalloproteinase (MMP)-1 expression. 5 Differences of all values, means ± SD, were assessed by two-way repeated measurements of analysis of variance (ANOVA) with post hoc test (Tukey-Kramer's test), and p<0.05 was considered significant.
Results
All rabbits in each group survived for 7 or 28 days. Echocardiographically, LVEF and EDD/BW on Day 28 was significantly improved in the Cy group (EF/(EDD/BW): 64±5%/4.2±0.4 mm/kg) compared with the values for S group [(EF/(EDD/BW): 53±4%/5.1±0.5 mm/kg)] (Fig 1) . The area of old infarct was significantly smaller in the Cy group (9.2±2.4%) than in the S group (19.2±4.1%), but no significant difference between the 5FU (15.6±3.4%) and S groups. The number of circulating CD34 + cells was significantly increased in the Cy (155±81 / L) and 5FU groups (81±41 / L) than in the S group (31±7 / L), but the increase in Cy was greater than in 5FU on Day 7. These treatments did not reduce the WBC until Day 7, and conversely increased it on Days 14 and 21. Cy was superior to 5FU or S (Fig 2) for neovascularization and MMP-1 expression, Fig 1. Cardiac function and size of the old infarct. In 28-day reperfused hearts, the cyclophosphamide-treated group (Cy; n=10) had a significantly reduced old infarct size and increased area of surviving myocardium, compared with the 5-fluorouracil-treated (5FU, n=10) or saline group (S, n=10). Accordingly, Cy significantly ameliorated left ventricular wall motion and remodeling. neovascularization and MMP-1 upregulation. To our knowledge, this is the first report of a beneficial effect of myelosuppressives in an infarcted heart. Cy and 5FU did not reduce the WBC until 7 days after MI, and it was increased thereafter, indicating mild myelosuppression followed by hyper-reaction. However, the increase in the number of circulating CD34 + cells was greater for Cy than 5FU. CD34 + cells facilitate regeneration of myocardium and/or secrete various cytokines that eventually beneficially affect cardiac repair. [3] [4] [5] Thus, the greater increase by Cy may explain the current differences in effect of Cy and 5FU. Anticancer treatment with myelosuppressives causes adverse effects such as marked myelosuppression, but in the current study, a dose of Cy caused mild myelosuppression that was beneficial for infarcted hearts, suggesting a potential for clinical application.
